Circ: DES can reduce TVR, but it depends on eluting drug Cardiovascular Business Researchers found that DES may be better at reducing the risk of target vessel revascularization without increasing other factors like stent thrombosis, and everolimus eluting stents may take the cake when compared to other DES. |
